HCAT Health Catalyst, Inc.
Nasdaq · SEC CIK 1636422 · EDGAR
- Bought, last 12 months
- $105.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $200.6K 2 sales by 2 insiders
- Filings on record
- 343 since 2021-07-06, latest 2026-09-16 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Larson-Green Julie | Dir | — | $128.2K |
| Kohl Simeon | CEO, Dir | $105.4K | — |
| Landry Benjamin | GC | — | $72.4K |
| Albert Benjamin | CEO, Dir | — | — |
| Hoggard Green Jill | Dir | — | — |
| Freeman Kevin Lee | Chief Commercial Off | — | — |
| Alger Jason | CFO | — | — |
| Burton Daniel D. | CEO, Dir | — | — |
| Gallagher Duncan | Dir | — | — |
| Llewelyn Linda | CHRO | — | — |
Transactions 414
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.79 | +1,828 | 24.6K | +8% | +$19.7K |
| DM | 2021-08-12 | 2021-08-10 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $54.31 | -4,020 | 23.9K | -14% | -$218.3K |
| DM | 2021-08-09 | 2021-08-05 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $55.80 | -10.8K | 118.3K | -8% | -$599.9K |
| D | 2021-08-09 | 2021-08-05 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +10.8K | 123.9K | +10% | +$170.3K |
| D | 2021-08-04 | 2021-08-02 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 80.5K | +3% | +$25.9K |
| D | 2021-08-04 | 2021-08-02 | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $58.04 | -2,500 | 78.0K | -3% | -$145.1K |
| DM | 2021-08-04 | 2021-08-02 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.13 | +3,300 | 37.2K | +10% | +$36.7K |
| D | 2021-08-04 | 2021-08-02 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $58.02 | -3,300 | 36.1K | -8% | -$191.5K |
| D | 2021-07-08 | 2021-07-06 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +10.8K | 123.9K | +10% | +$170.3K |
| DM | 2021-07-08 | 2021-07-06 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $57.00 | -10.8K | 119.8K | -8% | -$612.8K |
| DM | 2021-07-06 | 2021-07-01 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $55.87 | -3,260 | 36.1K | -8% | -$182.1K |
| DM | 2021-07-06 | 2021-07-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.14 | +3,150 | 37.2K | +9% | +$35.1K |
| DM | 2021-07-06 | 2021-07-01 | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $55.99 | -2,500 | 78.7K | -3% | -$140.0K |
| D | 2021-07-06 | 2021-07-01 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 80.5K | +3% | +$25.9K |
Purchase Sale Sale after option exercise All abbreviations